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650-Pos Structural effects of cardiotonic
compounds on the cardiac troponin C -
troponin I interface
Monica X. Li, Marta Oleszczuk, Ian M. Robertson, Karen
Freedman, Brian D. Sykes
Department of Biochemistry, University of Alberta, Edmonton, AB,
Canada.
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The interaction of cTnC and cTnI plays a critical role in transmitting
the Ca2þ-signal to the other myofilament proteins in heart muscle
contraction. As such, the cTnC-cTnI interface constitutes a logical
target for cardiotonic agents that can modulate the Ca2þ-sensitivity
of the myofilaments. We have shown that W7, a calmodulin
antagonist, binds specifically to the N-domain of cTnC, and this
binding can occur together with the switch region of cTnI (Li et al.,
2006, Biochemistry, 45, 9833–9840). We have made two stable
complexes, cNTnCCa2þcTnI144-163W7 and cTnC3Ca2þcTnI34–
71cTnI128–163W7 and are in the process of completing their NMR
structures. The first complex involves the regulatory domain of
cTnC and the key switch region of cTnI. The cTnI peptides in the
second complex encompass the three functional region of cTnI that
interact directly with intact cTnC. These two structures will provide
a detailed understanding of the mechanism underlining the mode of
action of W7 on the important functional units of cardiac troponin
and generate structural insights into the features that are important
for the design of cardiotoninc drugs. These structures will be
compared with those of cNTnCCa2þcTnI147–163bepridil (PDB
1LXF) and cCTnC2Ca2þEMD 57033 (PDB 1IH0) determined
previously in our laboratory and the X-ray structure of
sTnC4Ca2þsTnI1–182sTnT156–262anapoe (PDB entry 1YTZ).
Structural comparison will allow us to delineate the mechanism
underlining the mode of action of different cardiotonic drugs on the
cTnC-cTnI interface. This information can be exploited to develop
new, specific, and potent cardiotonic drugs that can be used in the
treatment of heart disease.
651-Pos Designing Troponin C Mutants
with Dramatically Altered Calcium
Dissociation Rates in Complex
Biochemical Systems
Svetlana Tikunova1, Bin Liu1, James D. Potter2, Aldrin V.
Gomes3, Darl R. Swartz4, Jonathan P. Davis1
1 The Ohio State University, Columbus, OH, USA
2University of Miami, Miami, FL, USA
3University of California, Davis, Davis, CA, USA
4Purdue University, West Lafayette, IN, USA.
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The influence of Ca2þ dissociation from TnC on the rate of cardiac
muscle relaxation is in dispute. One way to test whether TnC
controls relaxation is to directlymodify the rate ofCa2þ dissociation
from TnC by rationally engineered mutations. We have designed
twomutations, V44Q andD73N, expected to dramatically affect the
rate of Ca2þ dissociation from TnC in complex biochemical sys-
tems, without drastically altering TnI binding affinity. Neither
V44Q nor D73N mutation had a dramatic effect on the affinity of
Ca2þ saturated TnC for the regulatory fragment of TnI (residues
128–180). As predicted, V44Q increased the Ca2þ sensitivity of thin
filament bound TnC ~ 4.8-fold and ~1.7-fold, in the absence and
presence, respectively, of myosin S1. Consistent with its Ca2þ
sensitizing effect, V44Q led to ~5.0-fold and ~1.4-fold slower Ca2þ
dissociation rate from the thin filament bound TnC in the absence
and presence, respectively, of myosin S1. On the other hand,
mutation D73N decreased the Ca2þ sensitivity of thin filament
bound TnC ~ 4.0-fold and ~3.8-fold in the absence and presence,
respectively, of myosin S1. Consistent with its Ca2þ desensitizing
effect, D73N led to ~ 4.6-fold and ~ 4.2-fold faster rate of Ca2þ
dissociation from the thin filament bound TnC in the absence and
presence, respectively, of myosin S1. Furthermore, V44Q resulted
in a ~ 3.7-fold slower, while D73N resulted in ~ 2.7-fold faster Ca2þ
dissociation rate from TnC in rigor rabbit ventricular myofibrils.
These TnC mutants with dramatically altered Ca2þ dissociation
rates can be used to examinewhether TnC influences cardiacmuscle
relaxation.
(Supported byNIHK99HL087462 (to SBT), R01HL 042325 (to
JDP), R01 HL073828 (to DRS); and AHA 0160174B (To AVG),
0735079N (JPD).
652-Pos Functional Effects of Newly
Discovered Cardiac Troponin C-HCM
Mutations
Michelle Parvatiyar1, Jose R. Pinto1, Michelle A. Jones1,
Michael J. Ackerman2, James D. Potter1
1Univ of Miami Miller School of Medicine, Miami, FL, USA
2Mayo Clinic College of Medicine, Rochester, MN, USA.
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Troponin C has long remained elusive as a cardiomyopathy-sus-
ceptibility gene, however just recently Landstrom, et al. (AHA
abstract, 2007), have reported four newHCMmutations in TnC and
their effects on the Ca2þ sensitivity of force development. The
mutations A8V, C84Y, E134D and D145E were found in a large
cohort patient screen and occurred at the same prevalence as in other
sarcomeric genes, thus distinguishing TnC as a HCM-susceptibility
gene. In TnC depleted and reconstituted cardiac skinned fibers,
A8V, C84Yand D145E showed increased Ca2þ sensitivity of force
development whereas E134D did not. In addition to the functional
characterization in fibers, we performed Actomyosin ATPase, Fluo-
rescence and Circular Dichroism (CD) measurements to investigate
the molecular properties of these mutations. Actomyosin ATPase
data was collected using reconstituted filaments and demonstrated
that these mutations had varying degrees of activation, in the
presence of Ca2þ. No differences were observed in the Actomyosin
ATPase inhibition by these mutants. Fluorescence analysis was
evaluated using IAANS as extrinsic probe. Of the four mutants,
onlyD145E showed a small increase in the Ca2þ affinity of the Ca2þ
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specific site in the isolated state. In the CD experiments, there were
no modifications to the secondary structure in the APO state. Our
results clearly show that the Ca2þ binding properties of the isolated
TnC mutants do not predict the changes observed in the Ca2þ
sensitivity of force development.
Supported by NIH HL 42325 and NIH HL 67415.
653-Pos Effects of Single Residue
Mutations in Site II of Cardiac Troponin
C on Calcium Binding Affinilty and
Myofilament Calcium Sensitivity
Karen L. Reece, Richard L. Moss
University ofWisconsin School ofMedicine andPublicHealth,Madison,WI,
USA.
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Myocardial contraction is initiated when calcium binds to site II of
cardiac troponin C (cTnC). This 12-residue EF-hand loop (NH2-
DEDGSGTVDFDE-COOH) contains six residues (bold) that coor-
dinate calcium binding and six residues that do not appear to
influence calcium binding directly. We have made six single cyste-
ine substitutions (italics) within site II of cTnC to investigate
whether these residues are essential for calcium binding affinity in
isolation and calcium sensitivity of force development in single
muscle fibers. Calcium binding properties of mutant proteins were
examined in solution and after substitution into rat skinned soleus
fibers. While mutation of the serine eliminated a coordinating
oxygen thereby disrupting calcium binding, cysteine substitution
had no effect on calcium binding on cTnC in solution. However, as
part of the myofilament, the threonine mutation (T71C) reduced
calcium sensitivity while the phenylalanine mutation (F74C) in-
creased calcium sensitivity. Structural analysis using the available
crystal structures revealed that T71C introduced an additional
hydrogen bond with S35 in site I while F74C eliminated a hydrogen
bond with F20 in the A helix. There were no changes in hydrogen
bonding with the remaining three mutations of non-coordinating
residues. These results suggest that subtle changes in cTnC structure
alter myofilament calcium sensitivity. This study also reveals that
function of modified cTnC in solution does not necessarily correlate
to in situ function.
This work was supported by R01-HL61635.
654-Pos Troponin C as a Therapeutic
Target to Increase Cardiomyocyte
Contraction Without Affecting
Relaxation
F. Steven Korte, Anthony G. Rodriguez, Jin Dai, Charles E.
Murry, Michael Regnier
University of Washington, Seattle, WA, USA.
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Current pharmaceutical therapies for heart failure often target or
alter intracellular [Ca2þ] ([Ca2þ]i), which can have significant side-
effects such as arrhythmogenesis or adverse affects on diastolic
function. These drugs can also have unwanted actions in non-target
areas. In this study, we directly targeted cardiac thin filament
activation to enhance intact cardiomyocyte contraction independent
of altered [Ca2þ]i. Specifically, cardiac thin filament activation was
enhanced through adenovirally-mediated over-expression of a car-
diac troponin C (cTnC) mutant designed to have increased Ca2þ
binding affinity conferred by single amino acid subsititution
(L48Q). In skinned cardiac trabeculae and myofibrils we have
shown that substitution of L48Q cTnC for WT cTnC increases
Ca2þ sensitivity of force and themaximal rate of force development.
Over-expression of L48Q cTnC (identified by co-expression with
GFP) significantly increased the rate (L48Q ¼ 1.32 – 0.32 ML/s;
control¼ 0.45 – 0.14ML/s) and extent (L48Q¼ 9.1 – 2.2%; control
¼ 4.6 – 1.4%) of shortening as compared to control (GFP-expres-
sion only) in spontaneously contracting neonatal rat cardiomyo-
cytes. Importantly, the rate of relaxation was unaffected (L48Q ¼
0.43 – 0.11 ML/s; control ¼ 0.27 – 0.09 ML/s) by the presence of
L48Q cTnC. Expression of L48Q cTnC was confirmed by western
blot analysis of skinned myofibrils from transduced cardiomyo-
cytes, which indicated replacement of ~40% of WT cTnC with
L48Q cTnC. Future experiments will target cultured adult rat
cardiomyocytes. These experiments demonstrate the feasibility of
directly targeting cardiac thin filament proteins to enhance cardiac
contractility without altering diastolic function.
Supported by NIH HL07828 (FSK).
655-Pos Regulation of Asynchronous
Insect Flight Muscle by Troponin
Belinda Bullard1, Uros Krzic2, Gian Felice De Nicola3,
Kevin R. Leonard4, Annalisa Pastore3, Wolfgang A. Linke5
1University of York, York, United Kingdom
2EMBL, Heidelberg, Germany
3NIMR, London, United Kingdom
4EMBL/EBI, Cambridge, United Kingdom
5University of Munster, Munster, Germany.
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Asynchronous indirect flight muscle (IFM) is activated by sinusoi-
dal length changes at low [Ca2þ]. Work is produced as a result of
delayed activation by stretch and deactivation on release. The area of
loops on tension vs. length plots gives the work done by the fibre.
During oscillatory contraction, work loops are superimposed on
calcium-dependent isometric tension. In Lethocerus fibres, maxi-
mal oscillatory work was obtained at pCa 6, when isometric tension
was low. IFM has two isoforms of TnC: F1 with a single calcium
bound to the C-terminal lobe is needed for stretch-activation, and F2
with calcium bound to C- and N-lobes is needed for isometric
contraction; the ratio of F1:F2 is 7:1. We replaced endogenous TnC
with F1 or F2, orwith varying proportions of the isoforms.Workwas
maximal at F1:F2 ¼ 100:1, and often exceeded that for the native
fibre; with more F2, work was reduced as isometric tension in-
creased. At pCa 6, work produced by fibres with the in vivo F1:F2
ratio was close to that of the native fibre. The structure of F1 and the
interaction with TnI were studied by NMR and fluorescence spec-
troscopy. The N-lobe is in the closed conformation and, unexpect-
edly, the C-lobe is in the open conformation in both apo and
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calcium-loaded forms. The C-lobe interacts with the N-terminus of
TnI and, at lower affinity, with the switch and inhibitory peptide
region; both interactions are independent of calcium. The N-lobe
does not interact with TnI. Thus stretch activation needs a TnC that
binds calcium in the C-lobe without producing a structural change.
656-Pos A Novel Method of Measuring
Troponin Phosphorylation Levels
Andrew E. Messer, Clare E. Gallon, Steven B. Marston
Imperial College - NHLI, London, United Kingdom.
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We recently demonstrated that levels of troponin I (TnI) and
troponin T (TnT) phosphorylation could be measured in isolated
troponin from human tissue samples using SDS-PAGE and the Pro-
Q Diamond phosphoprotein specific gel stain. We have now devel-
oped a newmethod that enables us to determine the level of troponin
subunit phosphorylation directly without the need for calibrated
standards.
SDS-PAGE gels were made incorporating a phosphate-chelating
molecule linked to acrylamide.When thesewere run, themobility of
phosphoproteins was retarded in relation to the unphosphorylated
proteins and therefore formed separate bands according to their
phosphorylation level. We tested this system using recombinant
human cardiac TnI (supplied by C. Redwood, Oxford) phosphory-
lated by PKA. On phosphate-chelating gels, stained with SYPRO
Ruby, retarded bands corresponding to 1P, 2P, 3P and 4P appeared
whilst the original unphosphorylated TnI band disappeared. The
sum of the individual band volumes was constant.
The phosphorylated bands were identified by staining with Pro-Q
Diamond which also showed that the staining intensity (Pro-Q/
SYPRO Ruby) of the 1P band was half that of the 2P band. The 1P
species appeared with a half-life of 3–4minutes, peaked at 35min-
utes and slowly declined to half its maximal level at 120minutes.
The 2P species appeared with a half-life of 19minutes and levelled
off after 60minutes. The 3P and 4P species were first detected at
120minutes. At 240minutes the TnI species were 0P, 3.9%, 1P,
39.6%, 2P, 41.3%, 3P, 11.9% and 4P, 3.4% indicating that PKA can
phosphorylate sites in addition to serines 23 and 24. The total
phosphorylation time-course could be reconstructed from the band
volumes without the need for external calibration and this showed
that the TnI phosphorylation level reached 1.8molsPi/mol after
120minutes and was very similar to the curve determined using
radioactive ATP.
657-Pos Cardiac Troponin T: a Novel
Scaffold Protein, Anchors PKA to the
Myofilaments
C. Amelia Sumandea, Catherine H. Bozio, Levi Lampe,
Mary L. Garcıa-Cazarın, R. John Solaro, C. William
Balke, Marius P. Sumandea
University of Kentucky, Lexington, KY, USA.
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Cardiac troponin is a heterotrimeric protein complex that plays an
important role in regulating cardiac muscle contraction and relaxa-
tion. Increasing evidence suggests that cardiacmyofilament dynam-
ics are modulated by cTn alterations such as phosphorylation,
proteolysis etc. Using a yeast two-hybrid screen of a human heart
cDNA library, we identified previously nine novel proteins that
interact with cTnT, including cyclic AMP-dependent protein kinase
A (PKA). We repeated the screen using a different human heart
library and identified 159 clones that grew on high-stringency plates
and turned blue in the presence of a-gal, indicating positive inter-
actions with hcTnT. DNA sequencing of the clones is underway.
In the present study, we focused on elucidating themechanism by
which cTnT anchors PKA to the myofilaments and leads to cTnI
phosphorylation. HA-tagged PKA regulatory subunits Ia (RIa) and
IIa (RIIa), aswell asmyc-tagged cTnT,were individually expressed
using a rabbit reticulocyte lysate system. Association betweenmyc-
TnT and HA-PKAs was determined by immunoprecipitation (IP)
with agarose conjugated anti-myc and anti-HA antibodies. Our
results demonstrate that both HA-PKA-RI and -RII associate with
myc-cTnT, in vitro. Next, a GST-cTnT fusion protein was used in a
pull-down assay, followed by immuno-blotting, to verify whether
endogenous PKAs fromadult rat ventricularmyocytes bind to cTnT.
In order to determine the affinity of each PKA subunit for cTnTand
cTnI, a solid-phase ELISA assay was used. To produce enough
recombinant proteins for binding and subsequent phosphorylation
studies, PKA -RIa, -RIIa, and -catalytic domains were expressed in
E. Coli, and purified either by affinity (8-AEA-cAMP-Sepharose) or
by ion-exchange chromatography. Our study suggests that cTnT is a
novel scaffold protein, anchoring PKA to the myofilament in close
proximity to cTnI, thereby facilitating rapid phosphorylation of
cTnI-Ser23/Ser24 following b-adrenergic stimulation.
658-Pos Slow Skeletal Troponin T
Isoforms Decrease the Ca2þ Sensitivity
of Force Development and Increase the
Maximal Force in Skinned Cardiac
Muscle Fibers
Jose Renato Pinto, Michelle A. Jones, Jingsheng Liang,
James D. Potter
Univ of Miami Miller School of Medicine, Miami, FL, USA.
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Slow skeletal troponin T (SSTnT) mRNA expression has been
shown to be upregulated in the hearts of patients with end-stage
heart failure (Barton, et al, Mol Cell Biochem, 2004. 263:1 p. 91–
97). Nevertheless, the role of SSTnT in diseased hearts remains
unknown. At least three SSTnT isoforms have been found to exist in
slow skeletal muscle. To evaluate the function of each human
SSTnT isoform in cardiac muscle regulation, we have cloned,
expressed, purified, and performed skinned fiber experiments using
SSTnT1 (þ Exons 5 and 12), SSTnT2 (þ5, 12), SSTnT3 (5,
12) and SSTnTHYP (5,þ12 theoretical). All of the SSTnTs were
less soluble than adult cardiac troponin T (HCTnT3) at three
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different pHs. Skinned fiber experiments were performed using a
well established method of sequential TnT displacement and re-
constitution with a HCTnI.TnC complex. The extent of TnT dis-
placement was analyzed by the unregulated tension at pCa 8.0 after
TnT treatment and by western blot analyses. HSSTnT1, 2 and 3
showed a decrease in the Ca2þ sensitivity of force development
compared to HCTnT3. The maximal recovered force was signifi-
cantly increased in fibers displaced with HSSTnT1 and 3. In
contrast, HSSTnTHYP, showed an increase in the Ca
2þ sensitivity
of force development and no difference in maximal force recovered
compared to HCTnT3. The HSSTnT2 and HSSTnTHYP isoforms
showed improved relaxation of contraction. We conclude that
HSSTnT1, 2 and 3 decrease the Ca2þ sensitivity of force develop-
ment and increasemaximal force. TheHSSTnTHYP isoform showed
the opposite. These results suggest that the SSTnT isoforms play
distinct functional roles in muscle regulation and function in both
normal adult and diseased hearts.
Supported by NIH - AR050199, HL 42325 and HL 67415.
659-Pos Calcium Overloading Induces
Restricted N-terminal Truncation of
Cardiac Troponin T
Zhiling Zhang, Hanzhong Feng, J.-P. Jin
Evanston Northwestern Healthcare, Evanston, IL, USA.
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We previously reported that the N-terminal region of cardiac
troponin T (cTnT) could be selectively cleaved by mu-calpain
duringmyocardial ischemia reperfusion (Zhang et al.,Biochemistry
45:11681–94, 2006). To investigate the regulatory mechanisms, we
found that ex vivo myocardial infarction from ligation of the left
anterior descending coronary artery induced heart failure and
produced the N-terminal truncated cTnT (cTnT-ND) not only in
the infarct but also in remote zones. Acute increases in the afterload
of left OR right ventricle induced the production of cTnT-ND in
BOTH ventricles. This whole organ proteolytic response in isolated
working heart preparations indicates an independence of systemic
neurohumural mechanisms. The activating signal is likely trans-
duced from the stressed area to thewhole ventricles via a syncytium-
based mechanism. Ca(2þ)-overloading conditions could directly
induce myocardial production of cTnT-ND. Therefore, we propose
that increased calcium influx into cardiomyocytes in response to
ischemia reperfusion or pressure overloadmayplay a role to activate
the restricted proteolytic modification of cTnT. We are testing this
hypothesis by correlating the level of cytosolic Ca(2þ) and the
production of cTnT-ND in primary cardiomyocyte cultures. Ca(2þ)
overloading conditions are investigated for the induction of cTnT-
ND production. Together with our finding that the phosphorylation
states of cTnT may determine the production of cTnT-ND. It is
possible that intracellular calcium overload activates a protein
kinase pathway that phosphorylates cTnT to confer a higher sensi-
tivity to calpain cleavage. This study not only provides information
for the mechanism of cTnT-ND production in myocardial ischemia
reperfusion but also explores a potential new target formanipulating
myocardial contractility.
660-Pos Expression of a- and b-Isoforms
of Fast Troponin T During Skeletal
Muscle Differentiation and Adaptation
Stephen M. Chong, J.-P. Jin
ENH Research Institute, Evanston, IL, USA.
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The COOH-terminal region of troponin T (TnT) is largely con-
served among the three muscle fiber type isoforms. However, a
segment in the COOH-terminal region of fast skeletal muscle TnT is
regulated by alternative RNA splicing that produces the a- and b-
isoforms corresponding to themutually exclusive utilization of exon
16 or 17, respectively. This segment of TnT directly binds troponin I
(TnI) in the I-T arm of troponin and, therefore, its structural
regulation may have physiological importance. Splicing error can
cause a skipping of both exon 16 and exon 17, resulting in anmRNA
encoding truncated TnT protein. Using site-specific monoclonal
antibodies, we found that the truncated fast TnT proteinmay exist in
normal skeletalmuscles. Tropomyosin andTnI binding experiments
are carried out to investigate the potential negative impact of the
aberrant splicing product. We have previously reported that the a-
isoform of fast TnT is developmentally up-regulated and specific to
the mature fast skeletal muscle. We have further investigated the
distribution of the a- and b-isoforms in different types of adult
skeletal muscle tissues and fibers. Specific antibodies and quantita-
tive PCR were employed to analyze representative mouse skeletal
muscles (extensor digitorum longus, soleus and diaphragm mus-
cles) as well as in myoblasts during in vitro differentiation for the a-
and b-fast TnT contents. The regulation of exon 16/17 expression
duringmuscle adaptation is investigated in unloaded rat legmuscles
for correlations with the reduction of slow fiber contents and the
increase in high molecular fast TnT from N-terminal alternative
splicing.
661-Pos In Silico and In Vitro
Characterization of Cardiac Troponin T
Mutations Known to Cause Familial
Hypertrophic Cardiomyopathy
Pia J. Guinto, Edward P. Manning, Rachel K. Moore, Steven
D. Schwartz, Jil C. Tardiff
Albert Einstein College of Medicine, Bronx, NY, USA.
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FHC is a primary cardiac muscle disorder that is one of the most
common causes of sudden death in young people. The FHC
“hotspot” mutations at residue 92 in cardiac troponin T (cTnT), a
central modulator of thin filament regulation of myofilament acti-
vation, flank the proposed a-helical TNT1 tail domain. The flexi-
bility of TNT1has been suggested to be important in normal protein-
protein interactions within the thin filament. Through Molecular
Dynamics (MD) simulations, we have shown that FHC mutations
Arg92Leu and Arg92Trp result in increased flexibility at a critical
hinge region 18 Angstroms distant from the mutation. How do
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primary biophysical changes induced by these mutations cause
complex cardiomyopathies? MD shows replacement of residue
Arg92 with hydrophobic Leu and Trp results in local helical
compaction about themutation site and significant expansionwithin
the hinge region. MD simulations of Arg92Gln, a polar, uncharged
substitution, also show increased flexibility about the hinge region
with differences in a-helical characteristics compared to the hydro-
phobic substitutions. Arg92Lys simulations (a mutation with a
residue of similar polarity and charge) show no alteration in
flexibility or compaction-expansion regions in a-helical structure.
These observations imply a significant cause and effect relationship
due to the removal of an important polar, charged residue. We
hypothesize the flexibility alterations and compaction-expansion
regions in mutational segments would lead to electrostatic pertur-
bations, possibly interfering with cTnT-TM complex formation and
thin filament function. In vitromotility assays with wild type cTnT
and hotspot FHC-cTnT mutants are in progress to directly correlate
predicted alterations with resultant functional changes. Additional
simulations and motility assays comparing wild type cTnT with
FHC mutants will address the relative importance of electrostatic,
structural, and functional contributions to FHC pathogenesis.
662-Pos Alterations in myofibrillar
mechanics by psuedo-phosphorylation of
cardiac troponin I
Aaron C. Hinken1, Laurin M. Hanft2, Sadayappan
Sakthivel3, Jeffery Robbins3, Pieter P. de Tombe1, Kerry
S. McDonald2, R John Solaro1
1University of Illinois-Chicago, Chicago, IL, USA
2University of Missouri, Columbia, MO, USA
3 The Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA.
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The phosphorylation of specific serine and threonine residues on the
inhibitory subunit of cardiac troponin (cTnI) by various kinases
represents a major physiological mechanism for alteration of myo-
filament properties. Furthermore, altered thin filament function
plays an important role in the contractile dysfunction associated
with pathological outcomes such as heart failure. In this study we
investigated the effect(s) of chronic cTnI phosphorylation on myo-
filament function using skinned preparations from transgenic ani-
mals in which either only PKA phosphorylation sites (Ser-23/Ser-
24) (PP) or all of the possible PKA and protein kinase C (PKC)
phosphorylation sites (Ser-23/Ser-24/Ser-43/Ser-45/T-144) (All-P)
were replaced with aspartic acid to mimic a state of phosphoryla-
tion, as compared to wild-type cTnI replacement (WT). Left
ventricular cardiac myocytes from All-P transgenic mice exhibited
less Ca2þ sensitivity of force and produced lower levels of maximal
force (29 – 15 kN/m2) than both WT (52 – 10 kN/m2) and PP
transgenic myocytes (55 – 13 kN/m2). In addition, the economy of
force production was decreased in All-P left ventricular papillary
strips as compared to WT and PP. Moreover, while PKA treatment
yielded faster loaded shortening at high loads in WT and PP
transgenic myocytes, this effect was often blunted in myocyte
preparations from All-P transgenic mice. These results implicate
pseudo-phosphorylation at PKC sites on cTnI are important mod-
ulators of maximal force, Ca2þ sensitivity of force, and tension cost
of cardiac myofibrils. In addition, PKC phosphorylation of cTnI
attenuates the PKA-induced acceleration of myocyte loaded short-
ening, a process that appears to be modulated, at least in part, by
phosphorylation of MyBP-C. The data show PKC phosphorylation
of cTnI plays a primary role in depressing contractility, and there-
fore may contribute to the maladaptive behavior exhibited during
the progression to heart failure with increased PKC isozyme
activity.
663-Pos AMP Kinase Phosphorylates
Cardiac Troponin I on Multiple Sites
Raquel M. Sancho Solis1, Lisa Xu1, Huan He2, Carole L.
Nilsson2, Alan G. Marshall2, Ying Ge1, Jeffery W. Walker1
1University of Wisconsin - Madison, Madison, WI, USA
2 Ion Cyclotron Resonance Program, National High Magnetic Field Labo-
ratory, Tallahassee, FL, USA.
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AMP kinase is a serine/threonine protein kinase that becomes
activated when cellular AMP:ATP ratios rise, thereby serving as
a key regulator of cellular energetics. Among the known target
proteins phosphorylated by AMP kinase are catabolic and anabolic
enzymes (e.g. cardiac phosphofructokinase 2, acetyl CoA carbox-
ylase), but little is known about its ability to regulate the cardiac
contractile apparatus. Upon treatment of Triton X-100 skinned
mouse myocytes with recombinant catalytic subunit of AMP kinase
activated by the LKB1/STRAD/MO25 complex, we observed
incorporation of 32P from 32P-g-ATP into cardiac troponin I (cTnI)
and an unidentified protein at ~50 kDa. Purified human cTnI was
also readily phosphorylated by AMP kinase, in contrast to human
cardiac troponin Twhich was a poor substrate. Using a combination
of recombinant mouse cTnI with candidate sites mutated to alanine,
phosphospecific antibodies and high resolution MS/MS analysis of
synthetic peptide substrates,we identifiedSer22 as one of at least two
preferred sites phosphorylated by AMP kinase. Ser23 was not
phosphorylated by AMP kinase under the conditions employed.
By screening synthetic peptides mimicking selected regions of
cTnI, a second potential AMP kinase site was identified at Ser149.
AMP kinase was essentially refractory toward other sites including
Thr30 and three major PKC sites at Ser41/43 and Thr142. The results
indicate that AMP kinase phosphorylates cardiac troponin I with a
unique pattern characterized by selective targeting of one PKA site
and one p21-activated kinase (PAK) site, but no PKC sites. Func-
tional consequences on the contractile apparatus and its regulation
are under investigation.
664-Pos Altered Phosphorylation Of
cTnT And cTnI In SHR Myocardium
Mary L. Garcia-Cazarin, Prasanna K. Challa, Krishna S.
Vyas, Gail A. Sievert, Ye Chen-Izu, C. William Balke,
Marius P. Sumandea
University of Kentucky, Lexington, KY, USA.
226 Meeting-Abstract
Board B508
Spontaneously hypertensive rats (SHR) are the most extensively
studied animal models for human hypertensive heart disease. The
animals are pre-hypertensive during the first 4–6 weeks of life,
rapidly develop high systolic pressure, become fully hypertensive at
8–12 weeks of age and suffer sustained hypertension there after.
Cardiac hypertrophy develops gradually under hypertension be-
tween 3–18 months of age. Most animals suffer heart failure at 18–
24 months of age. The consistent pattern of a long period of stable
hypertrophy followed by a transition to failure provides a useful
model to study mechanisms of heart failure and to test different
phases of the disease process. The transition from compensated
hypertrophy to failure is accompanied bymarked changes in cardiac
function, which are associated with altered active and passive
mechanical properties of the myocardial tissue resulting in a
decrease force of contraction. However, the mechanisms responsi-
ble for this depression in function are poorly understood.
In this study, we test the hypothesis that changes in phosphoryla-
tion of cardiac troponin (cTnTand cTnI) in the aging SHR myocar-
dium leads to the progression of contractile dysfunction and ulti-
mately heart failure. Myofibrils isolated from left ventricular myo-
cardium of male SHR and age-matched WKY rats were probed for
total (ProQ Diamond) as well as site-specific (phospho-antibodies)
phosphorylation patterns. Our preliminary results indicate that cTnI
(Ser23/24; Thr144) and cTnT (Thr206; Ser278) are hyper-phos-
phorylated in the pre-hypertensive and hypertensive animals com-
pared to WKY controls. Interestingly, failing SHR myocardium
exhibits a dramatic de-phosphorylation of cTnI and cTnT. These
data implicate that regulation of cardiac myofilament function
through troponin phosphorylation is altered in SHR animals.
665-Pos Kinetic Study of the Interaction
between cTnI andActin: Effects of Ca2þ,
Strongly Bound S1 and PKA
Phosphorylation of cTnI
Jun Xing1, Herbert C. Cheung1, Wen-Ji Dong2
1University of Alabama at Birmingham, Birmingham, AL, USA
2Washington State University, Pullman, WA, USA.
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In cardiac muscle the interaction between the regulatory/inhibitory
(Rr/Ir) region of cTnI and actin is regulated by Ca2þ and strong
crossbridge and fine tuned by cTnI phosphorylation. The kinetics
associated with the interaction was investigated using FRET-based
stopped-flow to monitor the changes in the distance from actin
(Cys374) labeled with DABM as acceptor to the single cysteine
residues 151 or 167 of cTnImutant labeled with AEDANS as donor.
Studies with the thin filament (TF) reconstituted with labeled actin,
labeled cTnI, wild-type cTnC, cTnT and tropomyosin showed that
Ca2þ-binding induced the Rr/Ir region to move away from actin by
11~12A

. Ca2þ sensitivity andCa2þ dissociation-induced kinetics of
this structural transition were 5.70 ~ 5.74 (pCa50) and 85 ~ 120 s
1,
respectively. The strongly bound S1 caused the Rr/Ir region to move
further away by 3~7 A

and significantly increased Ca2þ sensitivity
and slowed down the kinetics. Phosphorylation of cTnI by PKA
decreased the Ca2þ sensitivity and increased the kinetics regardless
of the presence or absence of the strongly bound S1. Kinetics of the
structural transition between the Rr/Ir region of cTnI and actin
(Cys374) induced by the strongly bound S1 was measured by
mixing the Ca2þ-saturated thin filament with S1 in the presence
of ADP. On the TF reconstituted with wild-type cTnC, the kinetics
of the structural transition was 3 s1 and independent of cTnI
phosphorylation. However, when the Ca2þ-binding site II of cTnC
was deactivated in the TF reconstituted with cTnC(D65V/D67A),
the kinetic rate decreased to 0.6 s1. These results suggest that the
presence ofCa2þ promotes kinetics of strong crossbridge formation,
but the PKA phosphorylation of cTnI has no direct effects on the
kinetics of the crossbridge formation.
666-Pos Shift In Myosin Heavy Chain
Isoform Influences The Effect Of Slow
Skeletal Troponin I On Mouse Cardiac
Contractile And Myofiber Dynamic
Functions
Steven J. Ford1, R. John Solaro2, Murali Chandra1
1Washington State University, Pullman, WA, USA
2University of Illinois at Chicago, Chicago, IL, USA.
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In addition to changes in Myosin Heavy Chain (MHC) isoform
expression, developing murine embryos also undergo a transition in
Troponin I (TnI) isoform expression. The functional significance of
slow skeletal TnI (ssTnI) in the developing heart is not well
understood because ssTnI is expressed in the developing heart only
when b-MHC is the predominant isoform. Most studies on the
effects of ssTnI on cardiac function have been performed using
normal adult mice expressing a native a-MHC background. We
studied muscle fibers from native transgenic (TG) and non-trans-
genic (NTG) mice expressing cardiac specific ssTnI cardiac TnI,
respectively, as well as TG and NTG mice treated with 6-propyl-2-
thiouracil (PTU, a hypothyroidic chemical resulting in b-MHC
expression). Contractile function and myofiber dynamic measure-
ments were made in detergent-skinned fibers harvested from left-
ventricular papillary bundles of these mice. Myofilament calcium
sensitivity, as measured by pCa50, was significantly higher in ssTnI
TG mice only in the presence of a-MHC, (pCa50 ¼ 5.78–0.01 in
NTG mice vs 6.11–0.01 in TG mice). b-MHC expression blunted
this effect of ssTnI dependent increase in Ca2þ sensitivity (pCa50
¼ 5.85–0.01 NTG vs 5.90–0.01 TG). ssTnI increased the muscle-
length-dependent increase in the rate of XB-recruitment by 15% (b
¼ 16.72–1.23 NTG vs 19.16–0.66 TG) in the presence of a-MHC
and by 57% (b¼ 5.50–0.24 NTG vs 8.61–0.57 TG) in the presence
of b-MHC. Thus, ssTnI affected myofiber contractile dynamics
more significantly in the presence of b-MHC. These and other
contractile function and myofiber dynamic measurement data will
be discussed in more detail at the meeting.
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667-Pos Structure And Fly-casting
Mechanism Of The C-terminal Region
Of Troponin I By SDSL-EPR
Spectroscopy
James A. Cooke1, Paul M.G. Curmi2, Peter G. Fajer3, Louise
J. Brown1
1Macquarie University, Sydney, NSW, Australia
2 The University of New South Wales, Sydney, NSW, Australia
3Florida State University and The National High Magnetic Field Labora-
tory, Tallahassee, FL, USA.
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Several regions of the Troponin complex are highly flexible causing
complications in structural elucidation by traditional high-resolu-
tion techniques. One such important region is the C-terminal region
of the Tn inhibitory subunit (C-TnI), an alleged second actin-
binding domain. Futhermore, numerous mutations in C-TnI are
implicated in hypertrophic cardiomyopathy (HCM) thus inferring
significant functional importance for this region. Several contra-
dicting structural models of C-TnI have been suggested with most
describing a highly dynamic domain with at most a nascent second-
ary structure (Biophys. J 90:2436; J. Mol. Biol. 352:178). These
structures were proposed from data collected in the absence of the
actin thin filament - the proposed C-TnI binding partner.
We have utilised Site-Directed Spin Labeling Electron Paramag-
netic Resonance (SDSL-EPR) to elucidate the structure of theC-TnI
region of cardiac troponin in the reconstituted thin filament. The
MTSSL spin label was introduced at 9 consecutive cysteine residues
(cardiac 175–183) as engineered bymutagenesis of cardiac TnI. The
mobility of this region was highly dynamic but several regions
exhibited EPR trends consistent with a helical region. The C-TnI
was found to weakly interact with actin and we propose stronger
binding with actin further towards the TnI C-terminus. Inter-residue
spin distance measurements between labels within this C-TnI
domain are also consistent with this conclusion. Conformational
changes in the C-TnI region upon actin and Ca2þ binding from on-
going EPR scanning experiments in this region will be discussed.
Thin filament residue interactions within this region are further
compared to HCM mutations for structural/functional relevance.
668-Pos The Switch Peptide And N-
terminus cTnI Conformational Changes
As Measured By Deer And Dipolar Epr
jean chamoun, Likai Song, Brenda Schoffstall, Janush Pyka,
Peter G. Fajer
FSU, Tallahassee, FL, USA.
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The regulatory protein troponin complex (TnI, TnT and TnC)
triggers muscle contraction upon calcium binding. In the ON-state
(þCa2þ), the position of the cTnI switch peptide (150–159) is in
close proximity to the N-lobe of TnC (Takeda et al., Nature, 2003)
whereas in the OFF-state (Ca2þ) its location is unknown. One of
many possibilities is that the peptide is close to the coiled-coil region
of cTnT (226–275) and cTnI (90–136). We designed mutants with
labels on the N-lobe of TnC (TnC55) and adjacent to the switch
peptide (cTnI160) to probe theON-state and doublemutants of cTnI
with labels in the coiled-coil region (cTnI160/129, cTnI160/115,
and cTnI160/138) to probe theOFF state. Conventional dipolar EPR
and Double Electron-Electron Resonance (DEER) were used for
distance measurements between the different mutants in the recon-
stituted troponin complex. For the ON-state the measured distance
(TnC55/TnI160, 30 A

) is in agreement with the crystal structure. In
the OFF-state the switch peptide is closer to the coiled-coil
(cTnI160/129, 17 A

). These results support the proposed hypothesis
where the switch peptide moves towards the coiled-coil in the
absence of calcium. Cardiac muscle is regulated by the phosphory-
lation of serines (23/24) in the N-terminal extension which was
truncated in the construct used for crystal structure (Takeda et al.,
Nature, 2003). We suspect that phosphorylation induces the move-
ment of the N-terminal extension toward either the inhibitory region
(137–148) or the C-terminus of cTnI (200–210). We measured the
relative distance in both un-&-bisphosphorylated states between a)
N-terminus extension and the inhibitory region (TnI9/142) b) the N-
terminus extension and the C-terminus of cTnI (TnI9/209) in the
presence of calcium. Our preliminary results showed no distance
variation between un-&-bisphosphorylated states of TnI9/209 (48A

– 3 A

).
669-Pos The Restrictive
Cardiomyopathy Mutation In Troponin
I, R192H, Slows The Rate Of Ca2þ
Dissociation From Troponin C In
Reconstituted Thin Filaments
Bin Liu1, Svetlana B. Tikunova1, Jack A. Rall1, Darl R.
Swartz2, Jonathan P. Davis1
1The Ohio State University, Columbus, OH, USA
2Purdue University, West Lafayette, IN, USA.
Board B513
The human restrictive cardiomyopathymutation, troponin I R192H,
is associated with severe heart disease. This mutation in TnI is
located in the putative second tropomyosin-actin binding site. In
transgenic mice, the homologous human mutation causes diastolic
dysfunction in-vivo and gene transfer in rats leads to impaired
myocyte relaxation in-vitro. Previous studies have also demonstrat-
ed that the R192H mutation drastically increases the Ca2þ sensitiv-
ity of acto-myosin ATPase activity in reconstituted thin filaments
and force development in skinned cardiac preparations. We hypoth-
esized that the impaired relaxation and increased Ca2þ sensitivity of
themyofilaments was due to a slower rate of Ca2þ dissociation from
troponin C. At 15C, the rate of Ca2þ dissociation from isolated Tn
containing TnI R192H was not different from that containing the
wild type TnI. This result is consistent with a previous study that
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showed the Ca2þ sensitivity of isolated Tn was not affected by TnI
R192H. However, incorporation of TnI R192H into reconstituted
thin filaments (7 actin : 1 tropomyosin : 0.88 Tn) in the absence and
presence of myosin S1 (2 S1 per 7 actin) slowed the rate of Ca2þ
dissociation fromTnC ~2-fold compared to thewild type TnI. Thus,
on the thin filament, the rate of Ca2þ dissociation from Tn contain-
ing TnI R192H was always slower than the control and mechanisti-
cally explains the higher Ca2þ sensitivity of the myofilaments
caused by the TnI mutation. Furthermore, the data are consistent
with the hypothesis that slowing the rate of Ca2þ dissociation from
TnC slows cardiac muscle relaxation.
(Supported byNIHK99HL087462 (to SBT);RO1HL073828 (to
DRS); RO1AR020792 (to JAR); andAHASDG0735079 (to JPD)).
670-Pos Basal contractile function in
myocytes expressing cardiac troponin I
Ser43/45Ala
Dustin Robinson, Julie Rogers, Sarah Jimines, Margaret V.
Westfall
University of Michigan, Ann Arbor, MI, USA.
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In earlier work, protein kinase C-mediated phosphorylation of
cardiac troponin I Ser43/45 (cTnISer43/45) decreased myofilament
Ca2þ sensitivity and maximum force in permeabilized cells. How-
ever, it remains unclear whether the absence of phosphorylation at
this cluster directly influences basal contractile function in intact
myocytes. In addition, replacement of endogenous cTnI with mu-
tants containing substitutions of this site has not been examined in
myocytes from largermammals. Thegoal of the present studywas to
determinewhether troponin I with an Ala substitution at Ser43/45 is
incorporated equally well in rabbit and rat myocytes, and whether
this substitution significantly influences basal myocyte contractile
function. Expression and sarcomere shortening were measured in
adult rat and rabbitmyocytes after gene transfer of cTnISer43/45Ala
with and without a FLAG epitope. Western analysis showed>85%
replacement of endogenous cTnI with cTnIFLAG or cTnISer43/
45AlaFLAG in both rabbit and rat myocytes 4 days after gene
transfer. Expressed cTnISer43/45AlaFLAG was incorporated into
the sarcomere based on the comparable levels of replacement
measured in intact and permeabilized myocytes. Sarcomere short-
ening was measured in electrically paced, adult rat myocytes and
results in myocytes expressing cTnISer43/45Ala were compared to
myocytes expressing cTnIFLAG 4 days after gene transfer. In
preliminary functional studies, peak shortening and the rates of
contraction and relaxationwere comparable inmyocytes expressing
cTnISer43/45Ala and cTnIFLAG. These early results provide evi-
dence to indicate that basal Ser43/45 phosphorylation does not
significantly influence basal sarcomere shortening and re-lengthen-
ing in intact myocytes. Ongoing studies are now focused on
determining whether absence of this Ser cluster significantly influ-
ences the contractile response to PKC activation by endothelin.
671-Pos S23D/S24D, S23A/S24A
Mutations In Rat Cardiac Troponin I
Depress Myofilament Ca2þ Sensitivity,
MaximumTension AndATPase Activity
In Reconstituted Rat Cardiac Muscle
Fibers
RANGANATH MAMIDI, JASON DOBRY, STEVEN J.
FORD, MURALI CHANDRA
Washington State University, PULLMAN, WA, USA.
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Phosphorylation of cardiac troponin I (cTnI) at S23/24 is known to
decrease myofilament Ca2þ sensitivity. In this study, we used a
substitution mutant of cTnI (S23D/S24D) to determine if these
mutations altered contractile function other than myofilament Ca2þ
sensitivity.
Preliminary studies in our lab showed that reconstitution of both
S23D/S24D, S23A/S24Amutants resulted in a significant change in
contractile function parameters. Maximum Tension (S23D/S24D:
33.91 – 1.79, S23A/S24A: 31.77– 2.09), maximumATPase activity
(S23D/S24D: 146.68 – 7.86, S23A/S24A: 150.19 – 8.77) and
myofilament Ca2þ sensitivity, as measured by pCa50 (S23D/
S24D: 5.38 – 0.02, S23A/S24A: 5.42 – 0.01) of the fibers recon-
stituted with mutant Tn were significantly lower than fibers recon-
stituted with wild type recombinant RcTnI. Contractile parameters
of RcTnI were as follows: maximum tension (50.81 – 2.97),
maximum ATPase activity (210 – 6.0) and pCa50 (5.67 – 0.02).
Further experiments will be done to determine the underlying
source of the effects of cTnI mutants. Our preliminary data suggest
thesemutations affect the structure and function of cTnI as observed
by changes in the aforementioned contractile parameters.
672-Pos Troponin I interacts near
residue 146 of tropomyosin in a Ca2þ-
dependent manner
Wasana A. Mudalige, Terence Tao, Sherwin S. Lehrer
Boston Biomedical Research Institute, Watertown, MA, USA.
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The Ca2þ-dependent interaction of troponin I (TnI) with actin-
tropomyosin in the muscle thin filament is an important step in the
regulation of muscle contraction. Previous studies have suggested
that TnI interacts specifically with tropomyosin (Tm) in the recon-
stituted muscle thin filament and is involved in the Ca2þ-induced
movement of Tm (Potter&Gergely, Biochemistry, 1974; Zhou et al.
and Geeves et al., Biochemistry, 2000; Luo et al., JMB, 2002). To
obtain direct evidence for this interaction, and to determine the sites
of interaction we performed photochemical crosslinking studies
with 4-maleimidyl benzophenone (BPmal) labeled Tm at a single
Cys at position 146 or 174 (Tm146* or Tm174*), reconstituted with
Meeting-Abstract 229
troponin (TnI þTnT þTnC) and actin. After uv-irradiation, SDS-
gels of the Tm146* system showed 3 new high MW bands con-
firmed to be Tm146*-TnI, Tm146*-TnC and Tm146*-TnT using
both fluorescently labeled TnI and mass spectrometry. In contrast,
for Tm174* one main crosslinked band predominated attributed to
Tm174*-TnT. Interestingly, the Tm146*-TnI band was much more
intense when crosslinked in the absence of Ca2þ, in contrast to the
other crosslinked species which did not show a Ca2þ dependence.
These data show that in the thin filament:
5. a region of TnI interacts with Tm near position 146 in the
absence but not in the presence of Ca2þ;
6. a region of TnC is near Tm 146;
7. regions of TnT are near both Tm positions 146 and 174.
These data support a model in which the TnI-Tm interaction near
Tm146 is involved in the Ca2þ-dependent Tm movement and will
also aid in the location of the Tn complex along Tm in the muscle
thin filament.
Muscle Regulatory Proteins - II
673-Pos Tropomyosin Pseudo-
phosphorylation Alters its Interaction
Within the Thin Filament
Brandon J. Biesiadecki, Janel Jin, R. John Solaro
University of Illinois at Chicago, Chicago, IL, USA.
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The head-to-tail overlap region of the tropomyosin dimer is critical
to striated muscle contractile function. Tropomyosin contains a
single phosphorylation site at Ser-283 that is located directly within
the head-to-tail overlap region. During cardiac muscle development
tropomyosin phosphorylation is elevated while phosphorylation is
decreased in the adult suggesting a significant role for tropomyosin
phosphorylation in either sarcomeric assembly or in the regulation
of cardiac muscle contraction. To retain physiological function the
tropomyosin molecule must be acetylated at its N-terminal amino
acid residue. To date, all but a single study have investigated the
biochemical properties of phosphorylated tropomyosin using either
tropomyosin purified from muscle, that is likely to contain other
post-translational modifications, or recombinant E. coli expressed
tropomyosin containing an AS- tag. To investigate the effects of
native N-terminal acetylated tropomyosin phosphorylation in the
absence of other potentially confounding post-translational mod-
ifications we purified wild type and recombinant alpha tropomyosin
containing either phosphorylation-null (S283A) or pseudo-phos-
phorylation (S283D) mutations expressed in insect cells. ELISA
epitope analysis demonstrates tropomyosin pseudo-phosphoryla-
tion alters the binding of the monoclonal antibody CH1 to a central
epitope in the tropomyosin molecule suggesting a long-range
conformational effect of Ser-283 phosphorylation on the central
tropomyosin molecule. ELISA solid phase protein binding assays
demonstrate a significant increase in maximal binding of the
pseudo-phosphorylated tropomyosin to both troponin T and the
troponin complex compared to wild type and phosphorylation-null
tropomyosin in the absence of a significant effect on binding affinity.
These results demonstrate for the first time that recombinant
pseudo-phosphorylated tropomyosin exhibits altered interaction
with the troponin complex, further suggesting a role for tropomyo-
sin phosphorylation in cardiac muscle function.
674-Pos Effects of the Novel
Tropomyosin-Kappa on Modulating the
Mechanical Properties of the Heart
Chehade N. Karam1, Sudarsan Rajan2, Chao Yuan1, David F.
Wieczorek2, R John Solaro1
1University of Illinois at Chicago, Chicago, IL, USA
2University of Cincinnati, Cincinnati, OH, USA.
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Tropomyosin-kappa (TPM1k) is a newly discovered TM isoform
that is exclusively expressed in the human heart. Preliminary studies
indicate an increased expression of TPM1k in hearts of patientswith
dilated cardiomyopathy (DCM). TPM1k results from the alternative
splicing of the a-TM gene where the skeletal muscle exon 2b is
replaced with the smooth muscle exon 2a. In this study we sought to
determine the effect of the presence of TPM1k isoform on sarco-
meric response to Ca2þ. We generated transgenic (TG) mice ex-
pressing TPM1k in the cardiac compartment. About 60% of the
native TM was replaced with TPM1k. We compared force-pCa
relations in detergent extractedfiber (skinned) bundles isolated from
hearts of non transgenic (NTG) controls (n¼13) and TG-TPM1k
(n¼11) at a sarcomere length of 1.9 mm. Our data (mean – SEM)
demonstrated a significant decrease in the Ca2þ sensitivity of the
myofilaments (NTG: pCa50¼ 5.89 – 0.01; TG: pCa50¼ 5.72 – 0.01;
DpCa50¼ 0.18 – 0.01; P<0.0001) with no change in the maximum
developed tension (NTG: Fmax¼ 32.12 – 0.66mN/mm2; TG: Fmax¼
29.92 – 0.43 mN/mm2). To determine the effect of isoform switch-
ing on TM phosphorylation, we performed two-dimensional differ-
ence gel electrophoresis (2D-DIGE) followed by Pro-Q staining.
There was a decrease in the total phosphorylation of TPM1k
compared with that of a-TM. Our results fit with reports showing
a linkage of DCM to point mutations that decrease Ca2þ sensitivity,
and suggest a potential role of altered TM phosphorylation.
675-Pos Oxidation Of Tropomyosin By
Reactive Oxygen Species In The
Myocardium
Benjamin S. Avner, Lei Xiao, R. John Solaro
University of Illinois at Chicago, Chicago, IL, USA.
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Reactive oxygen species [ROS] generation is linked to acute and
chronic cardiac pathophysiological change and injury, and is known
to be increased in aging tissue. Sarcomeric components such as
tropomyosin [Tm] are critical in cardiac function and may be a
target of modification by ROS. The data presented test the hypothe-
sis thatROS inventricular tissue act throughoxidation of sarcomeric
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